Oral Semaglutide for Weight Loss
US$ 21.55
alternatives to glp-1 for weight loss OZEMPIC: Risks, Benefits, and Natural Weight-Loss Drugs Are there other non-GLP-1 options?
Description
When considering GLP-1 agonists for any indication, clinicians and patients must be aware of the established side effect profile of these medications
Other contributing factors that could perhaps influence this relationship include the level of pre-existing retinopathy, initial hemoglobin A1c levels, duration of diabetes, cotreatment with insulin, and comorbidities
The prevalence of insulin resistance in patients solely with PD is approximately 50% to 80%, and the prevalence of T2DM in patients with PD is 8% to 30% [36-40]
Larsson, S
2020;104(4S1 Suppl 1):S11103
